Is Revolution Medicines a Good Stock to Own?
Though it’s still quite early in the year, pharmaceutical startup…
Sell
32
VKTX Quote, Financials, Valuation and Earnings
Last price:
$31.86
Seasonality move
:
18.65%
Day range:
$31.86 - $34.90
52-week range:
$18.92 - $43.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.05x
Volume:
4.1M
Avg. volume:
3M
1-year change:
-8.55%
Market cap:
$3.6B
Revenue:
--
EPS (TTM):
-$2.12
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $277K | $296K | $291K | $292K | $346K | |
| Gross Profit | -$277K | -$296K | -$291K | -$292K | -$346K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $31.9M | $45M | $54.2M | $63.8M | $101.6M | |
| Selling, General & Admin | $10.7M | $10.7M | $16.1M | $37M | $49.3M | |
| Other Inc / (Exp) | $40K | $7K | -$42K | -- | $112K | |
| Operating Expenses | $42.4M | $55.4M | $70.1M | $100.5M | $150.6M | |
| Operating Income | -$42.7M | -$55.7M | -$70.4M | -$100.8M | -$150.9M | |
| Net Interest Expenses | $106K | $18K | $59K | $88K | $94K | |
| EBT. Incl. Unusual Items | -$39.5M | -$55M | -$68.9M | -$85.9M | -$110M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$39.5M | -$55M | -$68.9M | -$85.9M | -$110M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$39.5M | -$55M | -$68.9M | -$85.9M | -$110M | |
| Basic EPS (Cont. Ops) | -$0.54 | -$0.71 | -$0.90 | -$0.91 | -$1.01 | |
| Diluted EPS (Cont. Ops) | -$0.54 | -$0.71 | -$0.90 | -$0.91 | -$1.01 | |
| Weighted Average Basic Share | $72.6M | $77.2M | $76.8M | $94.3M | $109M | |
| Weighted Average Diluted Share | $72.6M | $77.2M | $76.8M | $94.3M | $109M | |
| EBITDA | -$42.4M | -$55.4M | -$70.1M | -$100.5M | -$150.6M | |
| EBIT | -$42.7M | -$55.7M | -$70.4M | -$100.8M | -$150.9M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$42.7M | -$55.7M | -$70.4M | -$100.8M | -$150.9M | |
| Operating Income (Adjusted) | -$42.7M | -$55.7M | -$70.4M | -$100.8M | -$150.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $75K | $142K | $73K | $87K | $114K | |
| Gross Profit | -$75K | -$142K | -$73K | -$87K | -$114K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.8M | $12M | $18.4M | $22.8M | $90M | |
| Selling, General & Admin | $2.6M | $4.2M | $8.9M | $13.8M | $8.6M | |
| Other Inc / (Exp) | -- | -- | -- | $109K | -- | |
| Operating Expenses | $13.3M | $16.1M | $27.2M | $36.5M | $98.4M | |
| Operating Income | -$13.4M | -$16.2M | -$27.3M | -$36.6M | -$98.6M | |
| Net Interest Expenses | -- | $27K | $2K | $24K | $8K | |
| EBT. Incl. Unusual Items | -$13.2M | -$15.8M | -$22.5M | -$24.9M | -$90.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$13.2M | -$15.8M | -$22.5M | -$24.9M | -$90.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.2M | -$15.8M | -$22.5M | -$24.9M | -$90.8M | |
| Basic EPS (Cont. Ops) | -$0.17 | -$0.21 | -$0.23 | -$0.22 | -$0.81 | |
| Diluted EPS (Cont. Ops) | -$0.17 | -$0.21 | -$0.23 | -$0.22 | -$0.81 | |
| Weighted Average Basic Share | $78M | $76.5M | $99.8M | $110.9M | $112.3M | |
| Weighted Average Diluted Share | $78M | $76.5M | $99.8M | $110.9M | $112.3M | |
| EBITDA | -$13.3M | -$16.1M | -$27.2M | -$36.5M | -$98.4M | |
| EBIT | -$13.4M | -$16.2M | -$27.3M | -$36.6M | -$98.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$13.4M | -$16.2M | -$27.3M | -$36.6M | -$98.6M | |
| Operating Income (Adjusted) | -$13.4M | -$16.2M | -$27.3M | -$36.6M | -$98.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $291K | $295K | $290K | $310K | $447K | |
| Gross Profit | -$291K | -$295K | -$290K | -$310K | -$447K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $44.2M | $47.9M | $59.5M | $91.2M | $222.5M | |
| Selling, General & Admin | $10.3M | $14.7M | $32.3M | $42.8M | $52.4M | |
| Other Inc / (Exp) | $26K | -$42K | -- | $111K | -- | |
| Operating Expenses | $54.1M | $62.3M | $91.5M | $133.7M | $274.4M | |
| Operating Income | -$54.4M | -$62.6M | -$91.8M | -$134M | -$274.8M | |
| Net Interest Expenses | $63K | $51K | $70K | $96K | $80K | |
| EBT. Incl. Unusual Items | -$53.6M | -$61.7M | -$80.8M | -$99.2M | -$237.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$53.6M | -$61.7M | -$80.8M | -$99.2M | -$237.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$53.6M | -$61.7M | -$80.8M | -$99.2M | -$237.4M | |
| Basic EPS (Cont. Ops) | -$0.70 | -$0.80 | -$0.92 | -$0.94 | -$2.12 | |
| Diluted EPS (Cont. Ops) | -$0.70 | -$0.80 | -$0.92 | -$0.94 | -$2.12 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$54.1M | -$62.3M | -$91.5M | -$133.7M | -$274.4M | |
| EBIT | -$54.4M | -$62.6M | -$91.8M | -$134M | -$274.8M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$54.4M | -$62.6M | -$91.8M | -$134M | -$274.8M | |
| Operating Income (Adjusted) | -$54.4M | -$62.6M | -$91.8M | -$134M | -$274.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $220K | $219K | $218K | $236K | $337K | |
| Gross Profit | -$220K | -$219K | -$218K | -$236K | -$337K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $35.1M | $38.1M | $43.3M | $70.7M | $191.5M | |
| Selling, General & Admin | $8M | $12M | $28.2M | $34M | $37.1M | |
| Other Inc / (Exp) | -- | -$42K | -- | $111K | $4K | |
| Operating Expenses | $43M | $49.9M | $71.3M | $104.4M | $228.3M | |
| Operating Income | -$43.2M | -$50.1M | -$71.5M | -$104.7M | -$228.6M | |
| Net Interest Expenses | $42K | $39K | $62K | $70K | $56K | |
| EBT. Incl. Unusual Items | -$42.6M | -$49.3M | -$61.3M | -$74.5M | -$202M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$42.6M | -$49.3M | -$61.3M | -$74.5M | -$202M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$42.6M | -$49.3M | -$61.3M | -$74.5M | -$202M | |
| Basic EPS (Cont. Ops) | -$0.55 | -$0.64 | -$0.67 | -$0.69 | -$1.80 | |
| Diluted EPS (Cont. Ops) | -$0.55 | -$0.64 | -$0.67 | -$0.69 | -$1.80 | |
| Weighted Average Basic Share | $230.7M | $230.8M | $277.2M | $324.8M | $336.5M | |
| Weighted Average Diluted Share | $230.7M | $230.8M | $277.2M | $324.8M | $336.5M | |
| EBITDA | -$43M | -$49.9M | -$71.3M | -$104.4M | -$228.3M | |
| EBIT | -$43.2M | -$50.1M | -$71.5M | -$104.7M | -$228.6M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$43.2M | -$50.1M | -$71.5M | -$104.7M | -$228.6M | |
| Operating Income (Adjusted) | -$43.2M | -$50.1M | -$71.5M | -$104.7M | -$228.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $248.4M | $202.1M | $155.5M | $362.1M | $902.6M | |
| Short Term Investments | $219.3M | $175.7M | $118.9M | $306.6M | $875.9M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $7.3M | $7.8M | $8.1M | $2.6M | $3.5M | |
| Other Current Assets | -- | $619K | $3.4M | $2.5M | $1.1M | |
| Total Current Assets | $256.1M | $210.5M | $167M | $367.2M | $907.2M | |
| Property Plant And Equipment | $321K | $25K | $1.4M | $1.1M | $1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $256.5M | $210.7M | $168.5M | $368.5M | $908.3M | |
| Accounts Payable | $4M | $1.4M | $8.5M | $7.5M | $9.8M | |
| Accrued Expenses | $7.8M | $7.3M | $13.1M | $11.3M | $17.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $330K | $29K | $304K | $324K | $489K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $12.1M | $8.8M | $21.9M | $19.1M | $27.4M | |
| Long-Term Debt | $29K | -- | $1.3M | $936K | $630K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $12.2M | $8.8M | $23.2M | $20.1M | $28M | |
| Common Stock | $1K | $1K | $1K | $1K | $1K | |
| Other Common Equity Adj | -$54K | -$549K | -$1.1M | -$389K | -$788K | |
| Common Equity | $244.3M | $201.9M | $145.3M | $348.4M | $880.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $244.3M | $201.9M | $145.3M | $348.4M | $880.3M | |
| Total Liabilities and Equity | $256.5M | $210.7M | $168.5M | $368.5M | $908.3M | |
| Cash and Short Terms | $248.4M | $202.1M | $155.5M | $362.1M | $902.6M | |
| Total Debt | $29K | -- | $1.3M | $936K | $630K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $216.1M | $155M | $376.2M | $930.4M | $714.6M | |
| Short Term Investments | $204.9M | $125.6M | $339.1M | $880.1M | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $7.2M | $9.2M | $4.4M | $4.5M | $21.9M | |
| Other Current Assets | -- | -- | $670K | $1.7M | -- | |
| Total Current Assets | $224.3M | $165.1M | $381.3M | $936.6M | $738.7M | |
| Property Plant And Equipment | $101K | $1.5M | $1.2M | $1.1M | $666K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $224.5M | $166.7M | $382.7M | $937.9M | $739.4M | |
| Accounts Payable | $2.9M | $3.1M | $5.7M | $254K | $4.4M | |
| Accrued Expenses | $8.4M | $10.6M | $7.4M | $25M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $115K | $299K | $319K | $480K | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $11.4M | $14.1M | $13.4M | $25.7M | $26.1M | |
| Long-Term Debt | -- | $1.3M | $1M | $755K | $318K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11.4M | $15.4M | $14.4M | $26.4M | $26.4M | |
| Common Stock | $1K | $1K | $1K | $1K | $1K | |
| Other Common Equity Adj | -$170K | -$1.8M | -$905K | $1.6M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $213.1M | $151.3M | $368.2M | $911.4M | $713M | |
| Total Liabilities and Equity | $224.5M | $166.7M | $382.7M | $937.9M | $739.4M | |
| Cash and Short Terms | $216.1M | $155M | $376.2M | $930.4M | $714.6M | |
| Total Debt | -- | $1.3M | $1M | $755K | $318K | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$39.5M | -$55M | -$68.9M | -$85.9M | -$110M | |
| Depreciation & Amoritzation | $277K | $296K | $291K | $292K | $346K | |
| Stock-Based Compensation | $5.8M | $6.1M | $8.7M | $16.8M | $29.7M | |
| Change in Accounts Receivable | $2.6M | $1.2M | $614K | $321K | $1.2M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$21.8M | -$47.6M | -$48.4M | -$73.4M | -$87.8M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $41.6M | $38M | $54.8M | -$179.1M | -$553.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | $6.8M | -- | -- | |
| Other Financing Activities | -$322K | -$753K | $10.1M | -$5.2M | $4.6M | |
| Cash From Financing | $950K | $6.9M | $4.2M | $271.4M | $612.5M | |
| Beginning Cash (CF) | $29.1M | $26.4M | $36.6M | $55.5M | $26.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $20.7M | -$2.7M | $10.3M | $18.9M | -$28.8M | |
| Ending Cash (CF) | $49.9M | $23.6M | $46.6M | $74.4M | -$2.3M | |
| Levered Free Cash Flow | -$21.8M | -$47.6M | -$48.4M | -$73.4M | -$87.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.2M | -$15.8M | -$22.5M | -$24.9M | -$90.8M | |
| Depreciation & Amoritzation | $75K | $142K | $73K | $87K | $114K | |
| Stock-Based Compensation | $1.6M | $1.9M | $4.5M | $9M | $7.3M | |
| Change in Accounts Receivable | -$11K | $151K | $246K | $1.3M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$10.9M | -$13.5M | -$19.7M | -$22M | -$94M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $13.6M | $26.9M | -$12.5M | $25.9M | $160M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$261K | -- | -$2M | -$46.7M | -- | |
| Cash From Financing | -$256K | $10K | -$74K | $2.5M | $480K | |
| Beginning Cash (CF) | $11.3M | $29.4M | $37.2M | $50.3M | $100.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$68K | -$29K | -$6K | |
| Additions / Reductions | $2.4M | $13M | -$32.3M | $6.4M | $66.5M | |
| Ending Cash (CF) | $13.7M | $42.4M | $4.8M | $56.8M | $166.9M | |
| Levered Free Cash Flow | -$10.9M | -$13.5M | -$19.7M | -$22M | -$94M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$53.6M | -$61.7M | -$80.8M | -$99.2M | -$237.4M | |
| Depreciation & Amoritzation | $291K | $295K | $290K | $310K | $447K | |
| Stock-Based Compensation | $5.7M | $8M | $14.8M | $28.1M | $37.9M | |
| Change in Accounts Receivable | $1.3M | $1.1M | $537K | $1.7M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$40.7M | -$49.8M | -$66.7M | -$74.2M | -$224.6M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $40.8M | $74.9M | -$207.6M | -$524.2M | $272.4M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $6.8M | -- | -- | -- | |
| Other Financing Activities | -$734K | -$518K | $3.5M | -$40.1M | -- | |
| Cash From Financing | $7.3M | -$6.5M | $281.9M | $611.7M | $2.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $7.4M | $18.1M | $7.8M | $13.2M | $50M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$40.7M | -$49.8M | -$66.7M | -$74.2M | -$224.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$42.6M | -$49.3M | -$61.3M | -$74.5M | -$202M | |
| Depreciation & Amoritzation | $220K | $219K | $218K | $236K | $337K | |
| Stock-Based Compensation | $4.7M | $6.5M | $12.7M | $24M | $32.2M | |
| Change in Accounts Receivable | $582K | $499K | $422K | $1.8M | $2.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$35.2M | -$37.5M | -$55.7M | -$56.6M | -$193.4M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $10.6M | $47.5M | -$214.8M | -$560M | $265.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $6.8M | -- | -- | -- | |
| Other Financing Activities | -$734K | -$499K | -$7.1M | -$42.1M | -- | |
| Cash From Financing | $6.8M | -$6.6M | $271.2M | $611.5M | $1.3M | |
| Beginning Cash (CF) | $36.9M | $58.1M | $125.1M | $289.8M | $172.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$80K | -$74K | -$17K | |
| Additions / Reductions | -$17.9M | $3M | $553K | -$5.2M | $73.7M | |
| Ending Cash (CF) | $19M | $61.1M | $125.5M | $284.6M | $245.9M | |
| Levered Free Cash Flow | -$35.2M | -$37.5M | -$55.7M | -$56.6M | -$193.4M | |
Related Companies
Get VKTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
VKTX
Sector
P/E ratio
--
23.92x
PEG ratio
-0.12x
-0.01x
P/B ratio
5.05x
1.81x
Price / LTM sales
--
1.60x
Growth Metrics
VKTX
Sector
Revenue growth
--
4.35%
Earnings growth
-259.4%
9.8%
Revenue (5-year growth)
--
6.41%
Earnings forecast
-$0.90
-$0.18
Profitability
VKTX
Sector
Profitability FY 2024
-$346K
$3.3M
Return on invested capital
-28.59%
-32.69%
Return on assets
-27.73%
-29.29%
Return on equity
-28.62%
-38.5%
Earnings Date
Last Earnings Date
Oct
22
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Jan
21
Balance Sheet
VKTX
Sector
Total cash
$714.6M
$25.6M
Short term investments
$875.9M
$25.1M
Total assets
$908.3M
$75.5M
Long term debt
$318K
$3.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Has Vistra Stock Gone Up?
Integrated power generation business Vistra (NYSE:VST) surprised investors recently when…
Why Is Amkor Stock Up So Much?
Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 64x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
80
BNR alert for Jan 16
Burning Rock Biotech Ltd. [BNR] is up 18.69% over the past day.
Sell
44
RGC alert for Jan 16
Regencell Bioscience Holdings Ltd. [RGC] is down 14.64% over the past day.
Buy
90
PEN alert for Jan 16
Penumbra, Inc. [PEN] is up 11.83% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
